Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Tianqing Chu, Runbo Zhong, Hua Zhong, +16

Journal of Thoracic Oncology

Phase 1BAdvanced NsclcSintilimab Plus AnlotinibOncologyClinical Therapeutic +4

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

Baohui Han, Bo Jin, Tianqing Chu, +13

International Journal of Cancer

Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy

Jun Lü, Hua Zhong, Tianqing Chu, +15

European Respiratory Journal

Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China

Anwen Xiong, Lei Wang, Jianhua Chen, +42

The Lancet

MedicineImmunologyPathologyImmune Checkpoint InhibitorCancer Treatment +4

Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer

Yan Zhou, Galina V. Shurin, Hua Zhong, +3

Cancer Research

Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung Cancer

Jianlin Xu, Haitang Yang, Xiaolong Fu, +8

Journal of Thoracic Oncology

Surgical OncologyRadiation TherapyMedicineThoracic SurgerySurgery +5

Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies

Jie Qian, Wei Nie, Jun Lü, +15

International Journal of Cancer

A cell-based quantitative high-throughput image screening identified novel autophagy modulators

Yuan Li, Steven R. McGreal, Jean J. Zhao, +5

Pharmacological Research

Cell AutophagyMitophagyEngineeringAutoimmune DiseaseNovel Autophagy Modulators +12

Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells

Lele Zhang, Jun Lü, Ruiqi Liu, +11

Acta Pharmacologica Sinica

Chromatin StructureMedicineCell BiologyLung Cancer CellsCancer Biology +4

Schwann cells promote lung cancer proliferation by promoting the M2 polarization of macrophages

Yan Zhou, Jingwen Li, Baohui Han, +2

Cellular Immunology

Tumor BiologyM2 PolarizationLung InflammationMedicineImmunology +10